Evexias BPC-157
BPC-157 (body protection compound) is an endogenous, stable pentadecapeptide composed of 15 amino acids, initially derived from gastric juices.
In various laboratory studies, synthetic BPC-157 has been reported to support the healing of wounds and certain injuries, promote recovery after tissue traumas, and limit the impact of systemic insults.
Although BPC-157 is known to have poor oral bioavailability, this challenge is effectively addressed through the use of a specialized liposomal tablet, which enhances both its bioavailability and overall efficacy.
BPC-157 (body protection compound) is an endogenous, stable pentadecapeptide composed of 15 amino acids, initially derived from gastric juices.
In various laboratory studies, synthetic BPC-157 has been reported to support the healing of wounds and certain injuries, promote recovery after tissue traumas, and limit the impact of systemic insults.
Although BPC-157 is known to have poor oral bioavailability, this challenge is effectively addressed through the use of a specialized liposomal tablet, which enhances both its bioavailability and overall efficacy.
BPC-157 (body protection compound) is an endogenous, stable pentadecapeptide composed of 15 amino acids, initially derived from gastric juices.
In various laboratory studies, synthetic BPC-157 has been reported to support the healing of wounds and certain injuries, promote recovery after tissue traumas, and limit the impact of systemic insults.
Although BPC-157 is known to have poor oral bioavailability, this challenge is effectively addressed through the use of a specialized liposomal tablet, which enhances both its bioavailability and overall efficacy.
